2024 Press releases
- Launch of the Gustave Roussy Prize to honor scientific innovation in oncology
Press release, 20 november 2024 - Cancer discovery - Discovery of a new prognostic biomarker in head and neck squamous cell carcinomas
Press release, 06 november 2024 - ESMO 2024 : Personalised treatments for soft tissue sarcomas
Press release, 16 september 2024 - ESMO 2024: Radiation therapy for women with breast cancer will now last for no more than three weeks
Press release, 15 september 2024 - ESMO 2024: Metastatic lung cancer: new therapeutic avenues are opening up thanks to the identification of resistance to targeted treatments
Press release, 14 september 2024 - ESMO 2024: A new medically promising antibody conjugate for metastatic breast cancer
Press release, 13 september 2024 - ESMO 2024: New hope in the treatment of thymus gland cancers
Press release, 13 september 2024 - Social inequalities widen after a breast cancer
Press release, 18 june 2024 - ASCO 2024 - Certain socio-economic factors influence adherence to a remote monitoring system
Press release, 4 June 2024 - ASCO 2024 - Virtual biopsy: IA can be used to map the response of tumour lesions to immunotherapy
Press release, 4 June 2024 - ASCO 2024 - Early screening for depressive symptoms in breast cancer
Press release, 3 June 2024 - ASCO 2024 - Promising results with anti-trop2 drug-conjugated antibody in metastatic lung cancer
Press release, 31 May 2024 - TheraSonic, a CEA spin-off created end of 2023, closes a fundraising led by the venture studio M2care for the development of a breakthrough technology designed to improve drug delivery into the brain
Press release, 14 may 2024 - New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery
Press release, 3 april 2024 - Research agreement between Gustave Roussy and Amgen to predict the effectiveness of antibodies drug conjugates
Press release, 28 march 2024 - The Lancet - A clinical trial proves the efficacy of sunitinib in the treatment of rare neuroendocrine tumors
Press release, 12 march 2024 - Leading European oncology center Gustave Roussy adopts OncoDNA’s OncoDEEP® Kit and automates library preparation and Target Enrichment using Bravo instrument
Press release, 1 march 2024 - Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice
Press release, 27th february 2024 - Nature journal - An innovative vision of cancer classification is indispensible for research and for patients
Press release, 31th january 2024 - The Department of Therapeutic innovation and early stage trials strengthened by the appointment of professor Chirstophe Massard as its head
Press release, 17th january 2024
Catégorie de la page:
